Kazazian Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.19M |
| 2 |
Bausch + Lomb
BLCO
|
+$668K |
| 3 |
Sarepta Therapeutics
SRPT
|
+$640K |
| 4 |
Boxlight
BOXL
|
+$365K |
| 5 |
NESR
National Energy Services Reunited Corp
NESR
|
+$163K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$11.5M |
| 2 |
Citigroup
C
|
+$10.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$9.39M |
| 4 |
Alibaba
BABA
|
+$5.45M |
| 5 |
Chewy
CHWY
|
+$3.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 33.29% |
| 2 | Consumer Discretionary | 29.06% |
| 3 | Financials | 19.37% |
| 4 | Technology | 8.29% |
| 5 | Industrials | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CALL
BridgeBio Pharma
BBIO
$16.6B
| – | – |
-9,700
| Closed | -$335K |
|
|
52
BridgeBio Pharma
BBIO
$16.6B
| – | – |
-11,840
| Closed | -$409K |
|
53
BILL Holdings
BILL
$4.91B
| – | – |
-5,272
| Closed | -$242K |
|
54
Cytokinetics
CYTK
$10.5B
| – | – |
-9,796
| Closed | -$394K |
|
55
iShares MSCI Mexico ETF
EWW
$1.91B
| – | – |
-4,168
| Closed | -$212K |
|
56
Exelixis
EXEL
$13.1B
| – | – |
-6,650
| Closed | -$246K |
|
57
Geron
GERN
$949M
| – | – |
-47,500
| Closed | -$75.5K |
|
58
Madrigal Pharmaceuticals
MDGL
$11.9B
| – | – |
-955
| Closed | -$316K |
|
59
MacroGenics
MGNX
$259M
| – | – |
-19,236
| Closed | -$24.4K |
|
|
MRUS
60
CALL
DELISTED
Merus
MRUS
| – | – |
-14,500
| Closed | -$610K |
|
|
MRUS
61
DELISTED
Merus
MRUS
| – | – |
-6,368
| Closed | -$268K |
|
62
Novartis
NVS
$298B
| – | – |
-1,819
| Closed | -$203K |
|
63
Okta
OKTA
$26.2B
| – | – |
-3,000
| Closed | -$316K |
|
64
Pfizer
PFE
$154B
| – | – |
-18,050
| Closed | -$457K |
|
65
Regeneron Pharmaceuticals
REGN
$83.2B
| – | – |
-560
| Closed | -$355K |
|
Similar funds
Kazazian Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Kazazian Asset Management held 65 positions worth $72.7M, down 41% from $123M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Kazazian Asset Management withdrew a net $62.7M in Q2 2025, closing 19 positions and reducing 35 holdings. Its most notable exit was Avadel Pharmaceuticals, an estimated $831K position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 33% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Kazazian Asset Management opened a new position in Alphabet (Google) Class A worth $1.28M.
- Kazazian Asset Management's largest Q2 2025 buy was Alphabet (Google) Class A: 7,240 shares worth $1.28M.
- Kazazian Asset Management added most to National Energy Services Reunited Corp in Q2 2025, an estimated $163K increase.
- Kazazian Asset Management's biggest Q2 2025 reduction was Walt Disney, cutting an estimated $11.5M.
- Kazazian Asset Management fully exited Avadel Pharmaceuticals in Q2 2025, selling an estimated $831K.
- Kazazian Asset Management's ten largest holdings make up 72% of its $72.7M portfolio in Q2 2025.
- Kazazian Asset Management opened 6 new positions and closed 19 in Q2 2025.
- Kazazian Asset Management's portfolio value fell 41% quarter-over-quarter to $72.7M.
Based on Kazazian Asset Management's 13F filing for Q2 2025, filed 11 Aug 2025.